JMP Securities Reaffirms "Market Outperform" Rating for Option Care Health (NASDAQ:OPCH)

Option Care Health (NASDAQ:OPCH - Get Free Report)'s stock had its "market outperform" rating reaffirmed by equities researchers at JMP Securities in a report issued on Wednesday,Benzinga reports. They presently have a $36.00 price objective on the stock. JMP Securities' price target would indicate a potential upside of 13.07% from the company's previous close.

Several other research analysts also recently commented on OPCH. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JPMorgan Chase & Co. increased their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Finally, Barrington Research reiterated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $31.84 on Wednesday. The company has a current ratio of 1.54, a quick ratio of 1.02 and a debt-to-equity ratio of 0.82. The stock has a fifty day simple moving average of $32.16 and a two-hundred day simple moving average of $30.42. Option Care Health has a 1-year low of $21.39 and a 1-year high of $35.53. The firm has a market cap of $5.21 billion, a price-to-earnings ratio of 25.68, a price-to-earnings-growth ratio of 1.92 and a beta of 0.74.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter in the prior year, the company earned $0.26 EPS. The firm's quarterly revenue was up 16.3% compared to the same quarter last year. Analysts anticipate that Option Care Health will post 1.22 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of OPCH. Murphy & Mullick Capital Management Corp purchased a new position in Option Care Health during the fourth quarter worth about $26,000. Signaturefd LLC increased its position in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock valued at $31,000 after purchasing an additional 836 shares in the last quarter. Quadrant Capital Group LLC raised its stake in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after purchasing an additional 1,099 shares in the last quarter. Finally, Brooklyn Investment Group lifted its position in Option Care Health by 186.6% during the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock valued at $42,000 after purchasing an additional 780 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.